This site is intended for healthcare professionals only
LoginRegister
Zydus Wellness Arm Faces Rs 6.3 Million GST Penalty Over ITC IrregularitiesZydus Lifesciences arm application for Menkes disease treatment gets USFDA priority review
Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to StelaraBiocon Biologics gets Japenese nod for Psoriasis Vulgaris injection Ustekinumab BS
Natco Pharma gets 7 USFDA observations for Kothur Pharma DivisionUSFDA issues EIR for Caplin Steriles Gummidipoondi facility
Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans AppealAbbott India Gets CDSCO Panel Nod To Conduct Phase III CT of Ursodeoxycholic Acid tablet
CSIR Indigenously developed Paracetamol announced by Dr Jitendra SinghCSIR Indigenously developed "Paracetamol" announced by Dr Jitendra Singh
Parliamentary Panel Slams CDSCO for Slow Drug Approvals, Calls for Conditional Licensing in 45 DaysCDSCO, ICMR Release Draft IVD Protocols for Arboviral Diagnostics, Seek Feedback
Parliamentary Panel Questions Rejection of NIMERs Proposal, Demands ExplanationParliamentary Panel Questions Rejection of NIMERs Proposal, Demands Explanation
Medicines worth Rs 6,975 crore in MRP terms sold through JAKs in last 10 yearsHealth Ministry grants additional one year relief to MSME pharma cos to upgrade facilities under...
Cipla, Hetero win bid to supply widely prescribed diabetes drug in China74000 capsules of illicitly diverted pharma drugs seized at Mumbai Airport
Bayer new drug application for gadoquatrane accepted for review in ChinaFederal Court brings end to Roundup litigation in Australia: Bayer
Drug Safety Alert: IPC Flags Blurred Vision Risk with Dacarbazine, Sexual Dysfunction Linked to DolutegravirDrug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Beta blockers
Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector VersionCDSCO panel approves Sanofi's proposal to increase number of subjects from 25 to 40 in india to...
X